The Scientific Review Panel is responsible for the evaluation of research grant applications. It consists of experienced researchers and clinicians who convene to discuss and rank applications based on rigorous criteria. Each member of the panel is carefully selected by the LLSC, in consultation with the appointed Chair, with varying expertise on blood cancer types and pose no conflict with the applicants. Once the applications are reviewed, the panel presents a recommendation for funding to the Medical & Scientific Advisory Committee.
Dr. Andrew Weng, Chair
Dr. Weng is a Distinguished Scientist in the Terry Fox Lab Department at BC Cancer Agency and a Professor in the Department of Pathology and Lab Medicine at University of British Columbia. He is also a practicing clinical hematopathologist and Director of the clinical flow cytometry lab at BC Cancer Agency. His research program is focused on pathogenetic mechanisms in acute T-cell leukemia and characterization of tumor/immune interactions in human B-cell lymphomas. His research has been published in top-tier biomedical journals. He has participated in grant review panels for LLSC, CIHR, CRS, and CCSRI in Canada, and NIH, LRF, and FLDOH in the US.